Literature DB >> 2835747

The down-regulation of the chicken cytoplasmic beta actin during myogenic differentiation does not require the gene promoter but involves the 3' end of the gene.

P Lohse1, H H Arnold.   

Abstract

The chicken cytoplasmic beta actin gene is ubiquitously expressed in all cell types. In terminally differentiated muscle cells, however, the concentration of beta actin specific mRNA is down-regulated to scarcely detectable levels. To test for gene regions which are involved in the muscle specific reduction of beta actin specific mRNA, the isolated complete chicken beta actin gene or chimeric gene constructs containing parts of the gene were stably transfected into the myogenic mouse cell line C2C12 and their transcriptional activity was compared in proliferating myoblasts and postmitotic myotubes. A hybrid construct containing the beta actin promoter fused to the bacterial CAT gene showed high and constitutive expression during myocyte differentiation. In contrast, constructs containing the SV40 early promoter linked to the 3' end of the beta actin gene led to a marked reduction of beta actin transcripts in differentiated C2C12 myotubes. The stability of beta actin mRNA was analyzed in actinomycin D treated cells and found to be virtually unchanged in myotubes as compared to myoblasts. These results suggest that a sequence element located in the 3' end or 3' flanking region of the beta actin gene confers the myotube specific down-regulation that is not primarily due to destabilization of mRNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835747      PMCID: PMC336433          DOI: 10.1093/nar/16.7.2787

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

Review 1.  Nonmuscle contractile proteins: the role of actin and myosin in cell motility and shape determination.

Authors:  M Clarke; J A Spudich
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

2.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

3.  Mammalian cytoplasmic actins are the products of at least two genes and differ in primary structure in at least 25 identified positions from skeletal muscle actins.

Authors:  J Vandekerckhove; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

5.  Changes in the mRNA population of chick myoblasts during myogenesis in vitro.

Authors:  B M Paterson; J O Bishop
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

6.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle.

Authors:  D Yaffe; O Saxel
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

7.  A myogenic cell line with altered serum requirements for differentiation.

Authors:  D Yaffe; O Saxel
Journal:  Differentiation       Date:  1977       Impact factor: 3.880

8.  At least six different actins are expressed in a higher mammal: an analysis based on the amino acid sequence of the amino-terminal tryptic peptide.

Authors:  J Vandekerckhove; K Weber
Journal:  J Mol Biol       Date:  1978-12-25       Impact factor: 5.469

9.  The complete amino acid sequence of actins from bovine aorta, bovine heart, bovine fast skeletal muscle, and rabbit slow skeletal muscle. A protein-chemical analysis of muscle actin differentiation.

Authors:  J Vandekerckhove; K Weber
Journal:  Differentiation       Date:  1979       Impact factor: 3.880

10.  Noncoding 3' sequences of the transferrin receptor gene are required for mRNA regulation by iron.

Authors:  D Owen; L C Kühn
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

View more
  8 in total

1.  A highly conserved enhancer downstream of the human MLC1/3 locus is a target for multiple myogenic determination factors.

Authors:  N Rosenthal; E B Berglund; B M Wentworth; M Donoghue; B Winter; E Bober; T Braun; H H Arnold
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

2.  Ribosomal protein L27 is identical in chick and rat.

Authors:  M C Lebeau; G Alvarez-Bolado; O Braissant; W Wahli; S Catsicas
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

3.  Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation.

Authors:  C Laker; J Meyer; A Schopen; J Friel; C Heberlein; W Ostertag; C Stocking
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  5' flanking and first intron sequences of the human beta-actin gene required for efficient promoter activity.

Authors:  R M Frederickson; M R Micheau; A Iwamoto; N G Miyamoto
Journal:  Nucleic Acids Res       Date:  1989-01-11       Impact factor: 16.971

5.  Promoter upstream elements of the chicken cardiac myosin light-chain 2-A gene interact with trans-acting regulatory factors for muscle-specific transcription.

Authors:  T Braun; E Tannich; G Buschhausen-Denker; H H Arnold
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

6.  A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts.

Authors:  T Braun; G Buschhausen-Denker; E Bober; E Tannich; H H Arnold
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

7.  Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12.

Authors:  T Braun; E Bober; B Winter; N Rosenthal; H H Arnold
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

8.  Transcription of the muscle regulatory gene Myf4 is regulated by serum components, peptide growth factors and signaling pathways involving G proteins.

Authors:  A Salminen; T Braun; A Buchberger; S Jürs; B Winter; H H Arnold
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.